Olema Pharmaceuticals Stock Options
| OLMA Stock | USD 4.41 0.04 0.92% |
Olema Pharmaceuticals' latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 2.96 with a put-to-call open interest ratio of 0.13 over 20 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on April 17th 2025. The total put volume is at 30.0.
Open Interest Against April 17th 2025 Option Contracts
2025-04-17
The chart above shows Olema Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Olema Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Olema Pharmaceuticals' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Olema Pharmaceuticals
Analyzing Olema Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Olema Pharmaceuticals regardless of its overall volatility. This is especially true when Olema Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Olema Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Olema Pharmaceuticals' stock while costing only a fraction of its price.
Olema Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of Olema Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Olema stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Olema Pharmaceuticals' stock price goes up or down, the stock options follow.
The current year's Sale Purchase Of Stock is expected to grow to about 574.8 K, whereas Total Stockholder Equity is forecasted to decline to about 193.8 M. Olema Pharmaceuticals In The Money Call Balance
When Olema Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Olema Pharmaceuticals stock is said to be in the money. When it comes to buying Olema Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Olema Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Olema Current Options Market Mood
Olema Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Olema Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Olema Pharmaceuticals' options investors are not very successful. Olema Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Olema contract
Base on the Rule 16, the options market is currently suggesting that Olema Pharmaceuticals will have an average daily up or down price movement of about 0.19% per day over the life of the 2025-04-17 option contract. With Olema Pharmaceuticals trading at USD 4.41, that is roughly USD 0.008158. If you think that the market is fully incorporating Olema Pharmaceuticals' daily price movement you should consider buying Olema Pharmaceuticals options at the current volatility level of 2.96%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Olema |
Purchasing Olema Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Olema calls. Remember, the seller must deliver Olema Pharmaceuticals stock to the call owner when a call is exercised.
Olema Pharmaceuticals Option Chain
When Olema Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Olema Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Olema Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Olema. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Olema. It also shows strike prices and maturity days for a Olema Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | OLMA250417C00025000 | 500 | 25.0 | 0.0 - 0.75 | 0.4 | Out |
Call | OLMA250417C00022500 | 10 | 22.5 | 0.0 - 0.75 | 1.35 | Out |
Call | OLMA250417C00020000 | 0 | 20.0 | 0.0 - 0.75 | 0.75 | |
Call | OLMA250417C00017500 | 22 | 17.5 | 0.0 - 0.05 | 1.1 | Out |
Call | OLMA250417C00015000 | 51 | 15.0 | 0.0 - 0.75 | 0.25 | Out |
Call | OLMA250417C00012500 | 11 | 12.5 | 0.0 - 0.75 | 0.36 | Out |
Call | OLMA250417C00010000 | 22 | 10.0 | 0.05 - 0.1 | 0.29 | Out |
Call | OLMA250417C00007500 | 16 | 7.5 | 0.0 - 2.55 | 0.65 | Out |
Call | OLMA250417C00005000 | 7 | 5.0 | 0.0 - 1.15 | 0.8 | Out |
Call | OLMA250417C00002500 | 1 | 2.5 | 0.1 - 4.8 | 6.5 | In |
Put | OLMA250417P00025000 | 0 | 25.0 | 20.2 - 21.7 | 20.2 | In |
Put | OLMA250417P00022500 | 0 | 22.5 | 17.5 - 18.4 | 17.5 | In |
Put | OLMA250417P00020000 | 0 | 20.0 | 15.2 - 15.9 | 15.2 | In |
Put | OLMA250417P00017500 | 0 | 17.5 | 12.7 - 13.4 | 12.7 | In |
Put | OLMA250417P00015000 | 0 | 15.0 | 10.2 - 10.9 | 10.2 | In |
Put | OLMA250417P00012500 | 0 | 12.5 | 7.6 - 8.4 | 7.6 | In |
Put | OLMA250417P00010000 | 0 | 10.0 | 5.2 - 6.1 | 2.65 | In |
Put | OLMA250417P00007500 | 10 | 7.5 | 1.55 - 3.5 | 2.1 | In |
Put | OLMA250417P00005000 | 75 | 5.0 | 0.0 - 1.15 | 0.82 | In |
Put | OLMA250417P00002500 | 0 | 2.5 | 0.0 - 1.0 | 1.0 |
Olema Total Stockholder Equity
Total Stockholder Equity |
|
Olema Pharmaceuticals Corporate Management
| JD Moriarty | Corporate Secretary | Profile | |
| Peter Kushner | CoFounder Fellow | Profile | |
| PharmD Faltaos | VP Pharmacology | Profile | |
| Kinney Horn | Chief Officer | Profile | |
| Cyrus Harmon | Chief Director | Profile | |
| Courtney Dugan | VP Communications | Profile | |
| John Moriarty | Chief VP | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Olema Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Olema Stock refer to our How to Trade Olema Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Olema Pharmaceuticals. If investors know Olema will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Olema Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Olema Pharmaceuticals is measured differently than its book value, which is the value of Olema that is recorded on the company's balance sheet. Investors also form their own opinion of Olema Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Olema Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Olema Pharmaceuticals' market value can be influenced by many factors that don't directly affect Olema Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Olema Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Olema Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Olema Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.